Idexx Laboratories
IDXX
1,153 hedge funds and large institutions have $41.1B invested in Idexx Laboratories in 2023 Q4 according to their latest regulatory filings, with 189 funds opening new positions, 350 increasing their positions, 425 reducing their positions, and 81 closing their positions.
133% more first-time investments, than exits
New positions opened: 189 | Existing positions closed: 81
38% more funds holding in top 10
Funds holding in top 10: 21 → 29 (+8)
27% more capital invested
Capital invested by funds: $32.4B → $41.1B (+$8.71B)
9% more funds holding
Funds holding: 1,059 → 1,153 (+94)
10% more call options, than puts
Call options by funds: $125M | Put options by funds: $114M
0.1% more ownership
Funds ownership: 89.16% → 89.26% (+0.1%)
18% less repeat investments, than reductions
Existing positions increased: 350 | Existing positions reduced: 425
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$528M |
| 2 |
BlackRock
New York
|
+$197M |
| 3 |
Millennium Management
New York
|
+$141M |
| 4 |
Capital Research Global Investors
Los Angeles,
California
|
+$115M |
| 5 |
TD Asset Management
Toronto,
Ontario, Canada
|
+$78.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GQG Partners
Ft. Lauderdale,
Florida
|
-$407M |
| 2 |
AllianceBernstein
Nashville,
Tennessee
|
-$182M |
| 3 |
American Century Companies
Kansas City,
Missouri
|
-$154M |
| 4 |
ESCM
Echo Street Capital Management
New York
|
-$111M |
| 5 |
Fundsmith LLP
London,
United Kingdom
|
-$111M |
IDXX Hedge Fund Activity: Q4 2023 in Review
1,153 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Idexx Laboratories (IDXX) for Q4 2023, worth a combined $41.1B — up 27% from $32.4B a quarter earlier.
Buyers outnumbered sellers: 189 funds opened new IDXX positions and 81 closed out — a net gain of 108 holders — while 350 added to existing stakes and 425 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $528M. The largest seller was GQG Partners, exiting entirely with an estimated $407M sold.
- 1,153 institutional investors held Idexx Laboratories (IDXX) as of Q4 2023, up from 1,059 in Q3 2023.
- Funds reported $41.1B of Idexx Laboratories stock for Q4 2023, up 27% quarter-over-quarter.
- 189 funds opened new Idexx Laboratories positions in Q4 2023 and 81 closed out, a net change of +108 holders.
- The largest Idexx Laboratories buyer in Q4 2023 was Morgan Stanley, an estimated $528M added.
- The largest Idexx Laboratories seller in Q4 2023 was GQG Partners, an estimated $407M sold.
Based on aggregated 13F filings for Q4 2023.